Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Einarsdottir BO"'
Autor:
Einarsdottir BO; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Karlsson J; Department of Medical Chemistry, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden., Söderberg EMV; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Lindberg MF; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Funck-Brentano E; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Jespersen H; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Brynjolfsson SF; Department of Microbiology and Immunology, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Bagge RO; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Carstam L; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Scobie M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Koolmeister T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Wallner O; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Stierner U; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Berglund UW; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Ny L; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Larsson E; Department of Medical Chemistry, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden., Helleday T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. jonas.a.nilsson@surgery.gu.se.
Publikováno v:
Cell death & disease [Cell Death Dis] 2020 Feb 06; Vol. 11 (2), pp. 99. Date of Electronic Publication: 2020 Feb 06.
Autor:
Bagge RO; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Demir A; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Karlsson J; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Alaei-Mahabadi B; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Einarsdottir BO; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jespersen H; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lindberg MF; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Muth A; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Nilsson LM; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Persson M; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Svensson JB; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Söderberg EMV; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Krijger RR; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Nilsson O; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Larsson E; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Stenman G; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Nilsson JA; , , , , , , , , , and , Sahlgrenska Academy, University of Gothenburg; , , , , , , , , , and , Sahlgrenska Cancer Center, University of Gothenburg; , , , , Sahlgrenska University Hospital, Gothenburg, Sweden; and , Reinier de Graaf Hospital, Delft; and University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2018 Jul 30; Vol. 2. Date of Electronic Publication: 2018 Jul 30 (Print Publication: 2018).
Autor:
Einarsdottir BO; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Karlsson J; Department of Medical Chemistry, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden., Söderberg EMV; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Lindberg MF; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Funck-Brentano E; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Jespersen H; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Brynjolfsson SF; Department of Microbiology and Immunology, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Olofsson Bagge R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Carstam L; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Scobie M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Koolmeister T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Wallner O; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Stierner U; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Berglund UW; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Ny L; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Larsson E; Department of Medical Chemistry, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden., Helleday T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. jonas.a.nilsson@surgery.gu.se.
Publikováno v:
Cell death & disease [Cell Death Dis] 2018 Jul 24; Vol. 9 (8), pp. 810. Date of Electronic Publication: 2018 Jul 24.
Autor:
Muralidharan SV; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden., Einarsdottir BO; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden., Bhadury J; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden.; The Institute of Medical Science, Division of Stem Cell Therapy, The University of Tokyo, Tokyo, Japan., Lindberg MF; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden., Wu J; Zenith Epigenetics Ltd, Calgary, Canada., Campeau E; Zenith Epigenetics Ltd, Calgary, Canada., Bagge RO; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden., Stierner U; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and The Sahlgrenska University Hospital, Gothenburg, Sweden., Ny L; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and The Sahlgrenska University Hospital, Gothenburg, Sweden., Nilsson LM; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden., Nilsson JA; Sahlgrenska Cancer Center, Department of Surgery or University Hospital, Gothenburg, Sweden.
Publikováno v:
Cell death & disease [Cell Death Dis] 2017 Aug 10; Vol. 8 (8), pp. e2982. Date of Electronic Publication: 2017 Aug 10.
Autor:
Lunavat TR; Krefting Research Center, Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg 405 30, Sweden., Cheng L; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, VIC 3010, Australia., Einarsdottir BO; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden., Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden., Veppil Muralidharan S; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden., Sharples RA; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, VIC 3010, Australia., Lässer C; Krefting Research Center, Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg 405 30, Sweden., Gho YS; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk, 790-784, Republic of Korea., Hill AF; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, VIC 3010, Australia., Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden., Lötvall J; Krefting Research Center, Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg 405 30, Sweden; jan.lotvall@gu.se.; Codiak BioSciences, Cambridge, MA 02139.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2017 Jul 18; Vol. 114 (29), pp. E5930-E5939. Date of Electronic Publication: 2017 Jul 06.
Autor:
Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T, Einarsdottir BO, Saleh A, Göktürk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Strömberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Bräutigam L, Johansson L, Höglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KSA, Wallner OA, Hammarström LGJ, Wiita E, Almlöf I, Kalderén C, Axelsson H, Djureinovic T, Carreras Puigvert J, Häggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jenmalm Jensen A, Artursson P, Nilsson JA, Stenmark P, Scobie M
Publikováno v:
Nature [Nature] 2017 Apr 26; Vol. 544 (7651), pp. 508.
Autor:
Warpman Berglund U; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Sanjiv K; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Gad H; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Kalderén C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Koolmeister T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Pham T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Gokturk C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Jafari R; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Maddalo G; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Seashore-Ludlow B; Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Chernobrovkin A; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Manoilov A; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Pateras IS; Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Rasti A; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Jemth AS; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Almlöf I; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Loseva O; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Visnes T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Einarsdottir BO; Sahlgrenska Translational Melanoma Group (SATMEG), Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg., Gaugaz FZ; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; Department of Pharmacy and., Saleh A; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Platzack B; Swedish Toxicology Sciences Research Center, Södertälje, Sweden., Wallner OA; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Vallin KS; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Henriksson M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Wakchaure P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Borhade S; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Herr P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Kallberg Y; National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm., Baranczewski P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Homan EJ; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Wiita E; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Nagpal V; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; SP Process Development, Södertälje, Sweden., Meijer T; SP Process Development, Södertälje, Sweden., Schipper N; SP Process Development, Södertälje, Sweden., Rudd SG; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Bräutigam L; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Lindqvist A; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Filppula A; Uppsala Drug Optimisation and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden., Lee TC; Institute of biomedical sciences, Academia Sinica, Taipei-115, Taiwan., Artursson P; Department of Pharmacy and.; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden.; Uppsala Drug Optimisation and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group (SATMEG), Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg., Gorgoulis VG; Biomedical Research Foundation of the Academy of Athens, Athens, Greece.; Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Lehtiö J; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Zubarev RA; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Scobie M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Helleday T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics thomas.helleday@scilifelab.se.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Dec; Vol. 27 (12), pp. 2275-2283. Date of Electronic Publication: 2016 Nov 08.
Autor:
Bhadury J; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Einarsdottir BO; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Podraza A; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Bagge RO; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Stierner U; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Ny L; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Dávila López M; The Bioinformatics Core Facility at the University of Gothenburg, Gothenburg, Sweden., Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Publikováno v:
Oncotarget [Oncotarget] 2016 Apr 26; Vol. 7 (17), pp. 23801-11.
Autor:
Einarsdottir BO; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Bagge RO; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Bhadury J; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Jespersen H; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Mattsson J; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Nilsson LM; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Truvé K; The Bioinformatics Core Facility at the University of Gothenburg, Gothenburg, Sweden., López MD; Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden. The Bioinformatics Core Facility at the University of Gothenburg, Gothenburg, Sweden., Naredi P; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Nilsson O; Department of Biomedicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Stierner U; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Ny L; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden., Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Sahlgrenska Translational Melanoma Group at the Sahlgrenska Cancer Center, Gothenburg, Sweden.
Publikováno v:
Oncotarget [Oncotarget] 2014 Oct 30; Vol. 5 (20), pp. 9609-18.
Autor:
Gad H; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Koolmeister T; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Jemth AS; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Eshtad S; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Jacques SA; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Ström CE; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2]., Svensson LM; Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Schultz N; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Lundbäck T; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Einarsdottir BO; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Department of Surgery, University of Gothenburg and Sahlgrenska University Hospital, S-405 30 Gothenburg, Sweden., Saleh A; Department of Analytical Chemistry, Stockholm University, S-106 91 Stockholm, Sweden., Göktürk C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Baranczewski P; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, S-751 23 Uppsala, Sweden., Svensson R; 1] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, S-751 23 Uppsala, Sweden., Berntsson RP; Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Gustafsson R; Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Strömberg K; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Sanjiv K; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Jacques-Cordonnier MC; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Desroses M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Gustavsson AL; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Olofsson R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Department of Surgery, University of Gothenburg and Sahlgrenska University Hospital, S-405 30 Gothenburg, Sweden., Johansson F; Department of Genetics, Microbiology and Toxicology, Stockholm University, S-106 91 Stockholm, Sweden., Homan EJ; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Loseva O; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Bräutigam L; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Johansson L; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Höglund A; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Hagenkort A; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Pham T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Altun M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Gaugaz FZ; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, S-751 23 Uppsala, Sweden., Vikingsson S; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Clinical Pharmacology, Department of Medical and Health Sciences, Linköping University, S-58185 Linköping, Sweden., Evers B; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1006 Amsterdam, The Netherlands (B.E.); Department of Immunology, Genetics, and Pathology, Uppsala University, S-751 23 Uppsala, Sweden (T.D.)., Henriksson M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Vallin KS; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Wallner OA; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Hammarström LG; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Wiita E; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Almlöf I; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Kalderén C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Axelsson H; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Djureinovic T; 1] Department of Genetics, Microbiology and Toxicology, Stockholm University, S-106 91 Stockholm, Sweden [2] Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1006 Amsterdam, The Netherlands (B.E.); Department of Immunology, Genetics, and Pathology, Uppsala University, S-751 23 Uppsala, Sweden (T.D.)., Puigvert JC; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Häggblad M; Science for Life Laboratory, RNAi Cell Screening Facility, Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Jeppsson F; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Martens U; Science for Life Laboratory, RNAi Cell Screening Facility, Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Lundin C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Lundgren B; Science for Life Laboratory, RNAi Cell Screening Facility, Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Granelli I; Department of Analytical Chemistry, Stockholm University, S-106 91 Stockholm, Sweden., Jensen AJ; 1] Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Artursson P; 1] Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden [2] Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, S-751 23 Uppsala, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Cancer Center, Department of Surgery, University of Gothenburg and Sahlgrenska University Hospital, S-405 30 Gothenburg, Sweden., Stenmark P; Department of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden., Scobie M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Berglund UW; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden., Helleday T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden.
Publikováno v:
Nature [Nature] 2014 Apr 10; Vol. 508 (7495), pp. 215-21. Date of Electronic Publication: 2014 Apr 02.